Keep reading as we dive into semaglutide doses, including information on compounded semaglutide, Ozempic, and Wegovy. Plus, check out our handy semaglutide weight loss dosage chart for an easy-to ...

This week, Novo Nordisk announced that people taking its mega-dose version of semaglutide lost substantially more body weight than usual in a large-scale trial. Novo Nordisk’s STEP UP trial ...

Unopened compounded semaglutide lasts in the fridge until the expiration date shown on the vial. But after it’s opened, compounded semaglutide only lasts in the fridge for 28 days. If you haven ...

Additionally, Heymsfield said more data are needed on whether the safety profile of semaglutide 7.2 mg differs from the 2.4 mg dose. Steven B. Heymsfield “The question is if that extra weight ...

Higher-dose weight loss injections now available." A new study increases max-dose guidance for semaglutide. This offers hope for those who didn’t reach their weight goals. The Injection and ...

Novo Nordisk has shared positive headline results from a late-stage study evaluating a higher dose of its GLP-1 receptor agonist semaglutide in adults with obesity. The phase 3b STEP UP trial has been ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is rolling out new data on a higher-dose injection in obesity. In the phase 3b ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...

The “Check Before You Inject” ad goes on to note that some vials of compounded semaglutide “have been found to contain dangerous impurities, banned substances, or incorrect doses.” ...

Detailed results from Novo's trial testing the higher dose of Wegovy, which contains the active ingredient semaglutide, are expected to be presented at a scientific conference in 2025, according ...

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...